Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.8 EUR | 0.00% | +0.98% | +96.32% |
06/05 | MORPHOSYS : UBS reiterates its Neutral rating | ZD |
30/04 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.32% | 2.71B | |
+21.03% | 46.4B | |
-1.34% | 41.75B | |
+48.09% | 41.37B | |
-3.52% | 29.71B | |
+10.17% | 26.01B | |
-19.86% | 19.52B | |
+30.20% | 12.43B | |
+0.61% | 12.18B | |
-0.54% | 12.13B |
- Stock Market
- Equities
- MOR Stock
- News MorphoSys AG
- MorphoSys : Royalty Pharma Takes Equity Position in MorphoSys for $100 Million